Dr. Reddy’s launches Deferasirox oral suspension and film-coated tablets in U.S.

Dr. Reddy’s Laboratories (NYSE:RDY) has launched Deferasirox Tablets for Oral Suspension and Deferasirox Film-Coated Tablets, 90 mg and 360 mg, a therapeutically equivalent generic version of Novartis Pharma AG’s Exjade (deferasirox) Tablets for Oral Suspension and Jadenu (deferasirox) Film-Coated Tablets 90, 180 and 360 mg, respectively.

The Exjade and Jadenu brand had U.S. sales of ~$113M MAT and $470M MAT, respectively for year ending in September 2019 according to IQVIA Health.

https://seekingalpha.com/news/3524321-dr-reddys-launches-deferasirox-oral-suspension-and-film-coated-tablets-in-u-s